VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 336 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2017. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $762,000 | -38.8% | 32,800 | -58.1% | 0.00% | -33.3% |
| Q1 2018 | $1,246,000 | -27.0% | 78,251 | -4.8% | 0.00% | -40.0% |
| Q4 2017 | $1,707,000 | +35.2% | 82,165 | -6.8% | 0.01% | +25.0% |
| Q3 2017 | $1,263,000 | -27.4% | 88,136 | -12.3% | 0.00% | -42.9% |
| Q2 2017 | $1,739,000 | -33.5% | 100,525 | +10.4% | 0.01% | 0.0% |
| Q1 2016 | $2,616,000 | -52.8% | 91,050 | +65.5% | 0.01% | -53.3% |
| Q4 2015 | $5,548,000 | +223.9% | 55,004 | +424.8% | 0.02% | +66.7% |
| Q3 2015 | $1,713,000 | -62.4% | 10,481 | -47.9% | 0.01% | -60.9% |
| Q2 2015 | $4,550,000 | +70.9% | 20,107 | +49.0% | 0.02% | +64.3% |
| Q1 2015 | $2,663,000 | +97.1% | 13,492 | +42.9% | 0.01% | +100.0% |
| Q4 2014 | $1,351,000 | -49.6% | 9,439 | -53.6% | 0.01% | -56.2% |
| Q3 2014 | $2,681,000 | -3.6% | 20,358 | -7.7% | 0.02% | 0.0% |
| Q2 2014 | $2,781,000 | +22.0% | 22,048 | +27.5% | 0.02% | +14.3% |
| Q1 2014 | $2,279,000 | -39.8% | 17,286 | -46.4% | 0.01% | -41.7% |
| Q4 2013 | $3,785,000 | +22.7% | 32,244 | +14.7% | 0.02% | +14.3% |
| Q3 2013 | $3,086,000 | +88.9% | 28,115 | +48.1% | 0.02% | +75.0% |
| Q2 2013 | $1,634,000 | – | 18,986 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |